arXiv Releases PMO-Dock: Standardizing Docking and Specificity in Molecular Optimization
Summary:arXiv introduces PMO-Dock, a benchmark and protocol for molecular optimization focused on docking tasks. Comprising 25 tasks covering hit generation, lead optimization, and a new specificity task, PMO-Dock addresses the lack of standardization in docking evaluation by separating model development from final evaluation and introducing a strict oracle budget to reflect real-world drug discovery settings. This benchmark provides a concrete standard for evaluating generalization to unseen tasks and
Background and Challenges
In the field of molecular optimization, the Practical Molecular Optimization (PMO) benchmark standardized evaluation practices. However, it relies on simple property-based oracles that fail to capture the nuances of structure-based drug design. As the field shifts towards docking-based objectives, evaluation practices have become fragmented, with different methods reporting results on various docking tasks without a shared protocol for fair comparison or sample efficiency constraints.
PMO-Dock Solution
To address these challenges, arXiv introduces PMO-Dock, a benchmark and protocol for docking-based optimization. It includes 25 tasks covering:
- Hit Generation: Assessing the ability of models to identify potential drug molecules.
- Lead Optimization: Optimizing existing molecules to enhance their efficacy and safety.
- Specificity Task: Requiring strong on-target binding while penalizing off-target interactions.
PMO-Dock achieves evaluation standardization through:
- Separation of Model Development and Final Evaluation: Using validation tasks for hyperparameter tuning and reserving test tasks for final evaluation to prevent data leakage.
- Strict Oracle Budget: Introducing a strict oracle budget during test task evaluation to reflect real-world drug discovery settings.
Methods and Results
The research team benchmarked four high-performing methods spanning different optimization paradigms:
- Saturn (Reinforcement Learning)
- GenMol (Discrete Diffusion)
- Genetic-guided GFlowNet (Genetic-guided Generative Flow Network)
- ChemLlama (LLM-based Evolutionary Search)
The results indicate that no single method is universally best across all tasks. Additionally, analyses of hyperparameter transfer (cross-task and cross-category) and sensitivity show that transfer capabilities are often limited and vary by method, which encourages method-dependent selection strategies.
Implications and Impact
PMO-Dock provides a concrete standard for evaluating the generalization of models to unseen tasks and their sample efficiency. Its rigorous evaluation process and diverse task design make it an essential tool in the drug discovery field, driving advancements in molecular optimization technologies.
Developer Recommendations
- Focus on Task Specificity: When selecting a model, prioritize methods that align with the specific requirements of the task rather than relying on a single 'best' model.
- Emphasize Hyperparameter Tuning: Leverage validation tasks for hyperparameter tuning to enhance model performance on new tasks.
- Consider Sample Efficiency: In resource-constrained environments, prioritize methods with higher sample efficiency.
— END —Source: ArXiv Machine Learning (cs.LG) (2026-10-15)
Tags: #Molecular Optimization #Benchmark #Drug Discovery #AI Drug Design #arXiv
Editorial & Fact-Checking Note: This article is compiled from primary research, official release documentation, and source papers by the ZICQ Newsroom pipeline with automated entity verification and human editorial review. If you notice any technical inaccuracy, please submit a correction via our corrections policy or email our editorial desk directly.
Community Comments